BioCentury
ARTICLE | Clinical News

Nobori regulatory update

January 28, 2008 8:00 AM UTC

Terumo received CE Mark approval for Nobori, a biolimus A9-eluting coronary stent, to treat restenosis. The company has exclusive marketing rights in Japan and non-exclusive rights in other countries,...